Product information and disease descriptionPlace of product in therapyDisease description
Pathophysiology
8 evidence topics · 4 sources
Energy homeostasis and the defended level of body fat
“Growing evidence suggests that obesity is a disorder of the energy homeostasis system, rather than simply arising from the passive accumulation of excess weight.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A major area of emphasis is the science of energy homeostasis, the biological process that maintains weight stability by actively matching energy intake to energy expenditure over time.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Central nervous system regulation of appetite and adipocyte mass
“The subcortical brain regions interact with higher cortical brain areas and hormonal signals (eg, leptin and gut hormones such as GLP-1) to regulate adipocyte mass.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Dysregulation in these neural circuits can lead to an imbalance between energy intake and expenditure, promoting uncontrolled fat accumulation, weight gain, and the development of obesity.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“NTS neurons express receptors for multiple satiety peptides such as leptin, melanocortin, and GLP-1, and are key contributors to satiety control.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Gut-derived incretin hormones: GLP-1 and GIP
“GLP-1 is secreted by L-cell enteroendocrine cells in the small intestine and colon in response to intraluminal nutrients, in particular glucose and fat.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“GLP-1 further influences nutrient utilization, as do other incretin hormones, by promoting insulin secretion and inhibiting glucagon secretion.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, drug trials consistently demonstrate that GLP-1 receptor agonism results in significant weight loss.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“GIP, like GLP-1, is an incretin hormone though it has previously been shown to have a minimal effect on weight.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“However, combination GIP and GLP-1 agonism results in robust weight loss, potentially related to GIP’s unique alterations in adipose cell lipid cycling” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Adipose tissue expansion, inflammation, and ectopic fat
“Hence, the pathophysiology of obesity not only involves an increase in total body fat, with preferential distribution to the intra-abdominal compartment in the presence of insulin resistance, but also ectopic lipid accrual into non-adipose tissues, especially in the liver, skeletal muscle, and the pancreas.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Storing excess energy in adipocytes is associated with ischaemia and hypoxia, apoptosis, fibrosis, and a decrease in capillary density.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Consequently, obesity functions as a chronically inflamed state that originates from adipose tissue but also occurs systemically.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Insulin resistance and cardiometabolic progression
“However, a clear majority of people with obesity suffer varying degrees of insulin resistance.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For someone with insulin resistance, the effects can be subclinical over much of their lifespan, but eventually give rise to clinical manifestations such as prediabetes, dyslipidaemia, hypertension, metabolic syndrome, and hepatic steatosis, contributing to the development of type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease (MASLD).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Mechanisms of organ dysfunction
“Obesity can directly cause organ dysfunction via several pathophysiological mechanisms, including the physical effect of increased adipose tissue mass, the presence of ectopic fat within tissues and organs, metabolic effects, inflammatory mechanisms, and psychological consequences (figure 3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Visceral adiposity and cardiovascular risk
“There may be a 2- to 3-fold variation in the amount of VAT at any level of total or subcutaneous adiposity.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Thus, high waist circumference (WC) even in individuals with normal weight may unmask higher CVD risk because WC is an indicator of abdominal body fat, which is associated with cardiometabolic disease and CVD and is predictive of mortality.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Pathophysiological and behavioral phenotypes
“Consequently, four actionable phenotypes were established: abnormal satiation (measured by calories ingested to experience postprandial fullness), abnormal postprandial satiety (duration of fullness and measured by GE), emotional eating behavior (measured by questionnaires) and abnormal resting energy expenditure (measured by indirect calorimetry).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This obesity-phenotype based classification aims to match a treatment to the underlying pathophysiological abnormality seen in patients with obesity.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote